Clinical trial
RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With…
NCT00259974 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00259974 |
|---|---|
| Title | RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
| Official title | Double-blind Randomized Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Groupe Hospitalier Pitie-Salpetriere University Hospital, Bordeaux University Hospital, Limoges Henri Mondor University Hospital University Hospital, Marseille Hospices Civils de Lyon University… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Polyneuropathy |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 60 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Dec 1, 2005 |
| Last update posted | May 6, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: